The TB-ELiFN kit is an enzyme linked immunosorbent assay (ELISA) for the quantitative determination of Interferon gamma (IFN-γ) released by memory T cells in human whole blood through in vitrostimulation with specific Mycobaterium tuberculosis (MTB) antigens. This test is an aid in the diagnosis of human tuberculosis (TB) infections.
This kit combines two principles, IGRA and ELISA, to measure the specific antigen mediated immune response. The antigens selected are present in MTB, but not bacille Calmette-Guerin (BCG) vaccine and most non-tuberculous mycobacteria. T cells in the whole blood from persons that have been infected with MTB will release IFN-γ when mixed with these specific antigens. The released IFN-γ is then quantitatively detected by a sandwich ELISA. The IFN-γ which are present in the blood will bind onto the wells of a microtitre plate (strip) supplied pre-coated with capture antibody. The bound IFN-γ are detected by the detection antibody labelled by horseradish peroxidase (HRP), which in turn is visualised by adding TMB solution. Any coloured product is measured at 450 nm after adding stop solution. The quantity of bound HRP varies directly with the concentration of IFN-γ in the blood sample tested; thus, the absorbance, at 450 nm, is a measure of the concentration of IFN-γ in the test sample. The quantity of IFN-γ in the test sample can be calculated from the standard curve constructed from the standards, and corrected for sample dilution.
Specific antigens employed in the kit are identified only in MTB; not in BCG strains or other most non-tuberculous mycobacteria.
A high throughput ELISA-based test system.
Components provided in ready-to-use format.
No cross-reactivity is found with other cytokines, e.g. IL-2 (40ng/ml), IL-4 (5ng/ml), IL-5, IL-6, IL-8, IL-10, IL12 (100ng/ml)
A specificity at 80.95% is reached with healthy volunteers.
Stable for at least 24 months when stored at 2-8°C.
Product Code: ELIFN-HTB-001
Packaging: 96 test
( 27 patient samples can be tested per kit )